McManus Kevin 4
4 · Omega Therapeutics, Inc. · Filed Mar 2, 2023
Insider Transaction Report
Form 4
McManus Kevin
Chief Human Resources Officer
Transactions
- Award
Option (Right to Buy)
2023-02-28+55,000→ 55,000 totalExercise: $6.46Exp: 2033-02-27→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]The options vest and become exercisable with respect to 25% of the underlying shares on February 28, 2024 and in equal quarterly installments thereafter such that the option will become fully vested and exercisable on February 28, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date.